Pharmaceutical Technology

JUNE 27, 2022

Cybersecurity is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 2.8% in May 2022.

147

147

Pharmaceutical Technology

JULY 27, 2022

Robotics is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 0.6% in June 2022.

130

130

Pharmaceutical Technology

JULY 13, 2022

Digitalization is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 11% in June 2022.

130

130

Pharmaceutical Technology

JULY 4, 2022

Cloud is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 6.3% in June 2022.

130

130

Pharmaceutical Technology

JUNE 23, 2022

Robotics is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 0.6% in May 2022.

130

130

Pharmaceutical Technology

NOVEMBER 8, 2022

Internet of things is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 0.9% in October 2022.

130

130

Pharmaceutical Technology

SEPTEMBER 21, 2022

Industrial automation is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 5.6% in August 2022.

130

130

Pharmaceutical Technology

NOVEMBER 7, 2022

Artificial intelligence is one of the topics that GlobalData, our parent company and from whom the data for this article is taken, have identified as being a key disruptive technology force facing companies in the coming years. less time on average compared to similar jobs across the entire jobs market.

Marketing 211

Marketing 211

Pharmaceutical Technology

AUGUST 10, 2022

Industrial automation is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 5.8% in July 2022.

130

130

Pharmaceutical Technology

AUGUST 8, 2022

Future of work is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 3.3% in July 2022.

130

130

Pharmaceutical Technology

AUGUST 3, 2022

Internet of things is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 0.9% in July 2022.

130

130

Pharmaceutical Technology

JULY 20, 2022

Internet of things is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 0.9% in June 2022.

130

130

Pharmaceutical Technology

JULY 11, 2022

Digital media is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 4.7% in June 2022.

130

130

Pharmaceutical Technology

JULY 8, 2022

Digitalization is one of the topics that GlobalData, our parent company and from whom the data for this article is taken, have identified as being a key disruptive technology force facing companies in the coming years. more time on average compared to similar jobs across the entire jobs market.

Marketing 147

Marketing 147

Roots Analysis

JANUARY 28, 2024

Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. Within the healthcare sector, structured data includes demographic details, vital indicators (like, height, weight, blood pressure, blood glucose).

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

Rethinking Clinical Trials

OCTOBER 18, 2023

Speaker Keith Marsolo, PhD Associate Professor Department of Population Health Sciences Duke University School of Medicine Slides Keywords PCORnet, Common Data Model, EHR, Social Determinants of Health Key Points There are many different definitions of social determinants of health. For example, consider food security.

Clinical Trials 117

Clinical Trials Clinical Trials Clinical Research Research 117

Rethinking Clinical Trials

JUNE 29, 2022

Associate Director for Real-World Evidence Analytics. Big data; Real-word evidence; Real-world data; 21st Century Cures Act; FDA Draft Guidance. Big Data, a term first used in the 1990s, leverages modern technology to increase the quantity, forms, speed, and capability to manipulate large-scale data. Key Points.

Big Data 130

Big Data Clinical Trials Clinical Trials Drugs 130

Rethinking Clinical Trials

OCTOBER 11, 2023

They found that involving methodologists familiar with clustered designs and their analytic and power issues was a key factor in their success. Second, you shouldn’t tell the staff collecting the outcome data which arm the various sites are in. However, I don’t have a great general solution for that issue at this point.

Clinical Trials 152

Clinical Trials Clinical Trials Trials Research 152

pharmaphorum

JANUARY 24, 2022

A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. For its part, IBM has said that the Watson for Oncology product has been improving year-on-year as the AI crunches more and more data.

Radiology 111

Radiology Marketing Genome Genomics 111

Pharmaceutical Technology

MARCH 22, 2023

The pharmaceutical industry began using radio frequency identification (RFID) tags in the early 2000s. Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. Twenty years ago, the cost of implementing RFID tags and the ecosystem (software) was much more expensive than today.

Production 264

Production Pharma Production Pharma Companies Drugs 264

Intouch Solutions

AUGUST 25, 2021

Updates to the Apple Mail app will allow users to change their privacy settings and allow Apple to hide their data in emails. There has been exponential growth in user concerns in recent years and, as a result, companies are addressing these concerns and becoming increasingly transparent about how they use consumer data.

Marketing 52

Marketing Regulation Engineer Branding 52

Drug Discovery World

OCTOBER 3, 2022

The seminars will include high profile speakers from pharma and biotech covering topics such as The Lab of the Future is Now, Data Handling and Choosing the Right Informatics System, The Sustainable Lab and The Remote Lab: Is This the Future? Dr Yahya Anvar, Head of Data Science, OKRA.ai Product Manager, SPT Labtech.

Drugs 52

Drugs Scientist Bioinformatics Medicine 52

Delveinsight

JULY 22, 2020

The Internet of Things is the interconnection of available medical devices, software applications and other resources to collect and exchange data to provide a reliable, efficient, and smart healthcare service to the patients. Sensors/Devices are the primary data collection point in IoT. New Insight/Data For Research.

Doctors 59

Doctors Doctor Marketing Production 59

Rethinking Clinical Trials

NOVEMBER 6, 2023

In this trial, the researchers were interested in three main data structures. In this trial, the researchers looked at five data generation mechanisms: fully nested, partially nested, crossed, crossed-interaction, and crossed-imbalanced. The second is the partially nested structure in which agents are only present in one arm.

Trials 130

Trials Clinical Trials Clinical Trials Contamination 130

Cloudbyz

JUNE 1, 2023

Record Triggers: Flow can respond to changes in Salesforce data, initiating processes when records are created or updated. They’re typically initiated by a change in record data. Integration: Salesforce Flow can integrate with external systems through callouts, giving it the ability to interact with data outside of Salesforce.

Compliance 79

Compliance Development Branding Production 79

Drug Discovery World

FEBRUARY 9, 2023

It also carries a much higher price tag for failure. We are entrenched in the era of big data and are amassing an insurmountable quantity of human-derived data to better inform our efforts in finding treatments. On top of that, pharmaceutical development is extremely complex in itself.

Drugs 52

Drugs Development Big Data Scientist 52

Drug Discovery World

NOVEMBER 9, 2023

Analytical characterisation of biotherapeutics The fifth track of PEGS Europe 2023 is ‘Analytical characterisation of biotherapeutics’, which will feature a range of sessions made up of presentations, talks and posters which address characterisation of novel biotherapeutics, and advances in analytical techniques and approaches.

Engineer 52

Engineer Antibody Protein In-Vivo 52

Roots Analysis

AUGUST 28, 2022

Furthermore, several live cell imaging and non-destructive fluorescence histological methods measure limited number of biomarkers at a time and the tags introduced may interfere with the natural function of genes and proteins. Our Social Media Platform. Web: [link]. LinkedIn: [link]. Twitter: [link]. Quora: [link].

Genome 52

Genome Genomics RNA Genome Project 52

pharmaphorum

DECEMBER 7, 2021

They used computational techniques to sift through genetic and other biologic data as well as insurance claims information from a database of more than 7 million patients, and found that sildenafil had the greatest potential as an Alzheimer’s drug.

Drugs 52

Drugs Clinical Trials Clinical Trials Scientist 52

Drug Discovery World

NOVEMBER 13, 2023

The presentations are as follows: Fabian Schmich, PhD, Senior Data Scientist, pRED Informatics, Roche Diagnostics Deutschland, on: ‘scifAI: An explainable machine learning framework applied to functional characterisation of therapeutic antibodies’.

Protein 59

Protein Antibody Engineer Scientist 59

Drug Discovery World

OCTOBER 21, 2022

Flow cytometry is a well-established analytical technique that has been supporting reliable diagnostics and groundbreaking research for decades. The main principle involves a well-defined light source such as that produced by lasers that excites fluorescent tags bound to the cells or particles present in a sample.

Reagent 52

Reagent Antibody Drugs Protein 52

Rethinking Clinical Trials

JUNE 14, 2023

Ongoing work we’re tackling is understanding that the methods and validity of trial emulation using EHR data or EHR-linked claims instead of claims data alone, as we used for these 32 trial emulations. We’ve also launched a spin-off project called ENCORE which is focused on emulating oncology trials using oncology specialty EHR data.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Pharma Marketing Network

JUNE 8, 2020

There’s what I call the real market and so this market really exploded, and I have data in this chapter about it. But I guess to be a bit of a contrarian and backed up with a lot of data. It essentially has two elements. Dave (HR): Oh, no, I think the Specialty Pharmacy. So yeah, there is plenty to talk about there.

HR 40

HR Marketing Doctors Doctor 40